Filing Details

Accession Number:
0001061983-20-000123
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-09 17:37:20
Reporting Period:
2020-07-07
Accepted Time:
2020-07-09 17:37:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061983 Cytokinetics Inc CYTK Pharmaceutical Preparations (2834) 943291317
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243004 D Sandford Smith 280 East Grand Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-07 5,232 $6.21 5,232 No 4 M Direct
Common Stock Disposition 2020-07-07 5,232 $27.00 0 No 4 S Direct
Common Stock Acquisiton 2020-07-07 6,510 $6.72 6,510 No 4 M Direct
Common Stock Disposition 2020-07-07 6,510 $26.00 0 No 4 S Direct
Common Stock Acquisiton 2020-07-08 1,434 $6.21 1,434 No 4 M Direct
Common Stock Disposition 2020-07-08 1,434 $27.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-07-07 5,232 $0.00 5,232 $6.21
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-07-08 1,434 $0.00 1,434 $6.21
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-07-07 6,510 $0.00 6,510 $6.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,768 2015-06-20 2025-05-20 No 4 M Direct
13,334 2015-06-20 2025-05-20 No 4 M Direct
0 2014-02-02 2024-01-02 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020.